Abstract
Epoxycarotenoids form a family of about 200 natural pigments present in photosynthetic organisms, fungi, and animal and human tissues. Numerous studies have evidenced that they exert strong antiproliferative, cytotoxic and proapoptotic activities in cancer cells grown in vitro, and that some of them are resorbed per os, suggesting that they may prevent cancer in vivo. This paper presents a comprehensive description of epoxycarotenoids reported up to 2011 (chemical structure, natural sources, human and animal absorption studies, physiological metabolites) and reviews their biological activity in cancer cells grown in vitro (antiproliferative, cytotoxic and pro-apoptotic activities; molecular and pharmacological targets, ability to reverse multidrug resistance, anti-angiogenic activity).
Keywords: Epoxycarotenoid, carotenoid, epoxyxanthophyll, pigment, cancer, MDR, photosynthetic organisms, antiproliferative, cytotoxic, pro-apoptotic.
Current Bioactive Compounds
Title:Epoxycarotenoids and Cancer. Review
Volume: 8 Issue: 2
Author(s): Anne-Laure Gagez, Valerie Thiery, Virginie Pasquet, Jean-Paul Cadoret and Laurent Picot
Affiliation:
Keywords: Epoxycarotenoid, carotenoid, epoxyxanthophyll, pigment, cancer, MDR, photosynthetic organisms, antiproliferative, cytotoxic, pro-apoptotic.
Abstract: Epoxycarotenoids form a family of about 200 natural pigments present in photosynthetic organisms, fungi, and animal and human tissues. Numerous studies have evidenced that they exert strong antiproliferative, cytotoxic and proapoptotic activities in cancer cells grown in vitro, and that some of them are resorbed per os, suggesting that they may prevent cancer in vivo. This paper presents a comprehensive description of epoxycarotenoids reported up to 2011 (chemical structure, natural sources, human and animal absorption studies, physiological metabolites) and reviews their biological activity in cancer cells grown in vitro (antiproliferative, cytotoxic and pro-apoptotic activities; molecular and pharmacological targets, ability to reverse multidrug resistance, anti-angiogenic activity).
Export Options
About this article
Cite this article as:
Gagez Anne-Laure, Thiery Valerie, Pasquet Virginie, Cadoret Jean-Paul and Picot Laurent, Epoxycarotenoids and Cancer. Review, Current Bioactive Compounds 2012; 8 (2) . https://dx.doi.org/10.2174/157340712801784787
DOI https://dx.doi.org/10.2174/157340712801784787 |
Print ISSN 1573-4072 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6646 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Editorial (Thematic Issue: Rheumatic Diseases as the Fuel to Inflamm-aging)
Current Aging Science Pharmaceutical Interventions for Frailty and Sarcopenia
Current Pharmaceutical Design Suicide Gene Therapy Against Malignant Gliomas by the Local Delivery of Genetically Engineered Umbilical Cord Mesenchymal Stem Cells as Cellular Vehicles
Current Gene Therapy Arachidonic Acid Derivatives and Neuroinflammation
CNS & Neurological Disorders - Drug Targets Molecular Signatures of Biomarkers in Cancer Development, Diagn osis, and its Prognostic Accuracy
Current Biomarkers (Discontinued) Recent Advances in Hematopoietic Stem Cell-Mediated Regeneration
Recent Patents on Regenerative Medicine Editorial (Thematic Issue: Ceramics, Nanotubes, Advanced Materials: Theoretical and Experimental Structure-Property Relationships Part IV)
Current Physical Chemistry Chondroitin Sulphate: Antioxidant Properties and Beneficial Effects
Mini-Reviews in Medicinal Chemistry Ginsenoside Rb1 Directly Scavenges Hydroxyl Radical and Hypochlorous Acid
Current Pharmaceutical Design Amniotic Fluid Embolism: What Level of Scientific Evidence can be Drawn? A Systematic Review
Current Pharmaceutical Biotechnology Nanoparticles-Based Treatment for Bone Metastasis
Current Drug Targets Comparison of Triflusal with Aspirin in the Secondary Prevention of Atherothrombotic Events; Α Randomised Clinical Trial
Current Vascular Pharmacology Current & Future Therapies of Erectile Dysfunction in Neurological Disorders
Recent Patents on CNS Drug Discovery (Discontinued) Targeting the Akt/PI3K Signaling Pathway as a Potential Therapeutic Strategy for the Treatment of Pancreatic Cancer
Current Medicinal Chemistry PF-04886847 (an Inhibitor of Plasma Kallikrein) Attenuates Inflammatory Mediators and Activation of Blood Coagulation in Rat Model of Lipopolysaccharide (LPS) - Induced Sepsis
Cardiovascular & Hematological Agents in Medicinal Chemistry Disentangling the Intricacies of Migraine: A Review
CNS & Neurological Disorders - Drug Targets Hepatic MicroRNA Orchestra: A New Diagnostic, Prognostic and Theranostic Tool for Hepatocarcinogenesis
Mini-Reviews in Medicinal Chemistry Cellular Oxidative/Antioxidant Balance in γ-Irradiated Brain: An Update
Mini-Reviews in Medicinal Chemistry Biologic Agents in the Treatment of Psoriasis
Recent Patents on Inflammation & Allergy Drug Discovery Three Dimensional Molecular Field Analysis of Thiomorpholine Analogs of TACE Inhibitors Using Receptor Based Alignment
Letters in Drug Design & Discovery